Invitation Letter | The 3rd Clinical Research Institution Exhibition and Guangzhou Clinical Research Industry Trade Fair

Media Center

》 Exhibition Dynamics 》 Industry News 》 Media Coverage 》 Exhibition Photo 》 Exhibition Video 》 Partner

Current Location：Home Media Center Exhibition Dynamics

Author：Clinical Research Association Time：2024-11-22 Reader：52

Background of the event

The clinical research industry, as an important component of the biopharmaceutical field, has rapidly developed globally in recent years. The biopharmaceutical industry is a strategic emerging industry that is a key focus of national development. The government has introduced policies to encourage and support the development of the biopharmaceutical industry, including increasing research and development investment, optimizing approval processes, and providing tax incentives, providing strong policy support and a favorable development environment for the clinical research industry.

Medical institutions play an important role in supporting the healthy development of the clinical research industry. They can provide clinical evaluation data and evidence as participants in registered clinical trials in the biopharmaceutical industry, as well as support the clinical research (IIT) initiated by their own researchers to generate research results and gain benefits from the application and transformation of these results.

As of now, there are over 1500 medical institutions in China that have completed the registration of drug and device clinical trial institutions, with about 30000 registered researchers. Experienced institutions need brand building, and many institutions urgently need to achieve zero breakthroughs and expand project cooperation sources. The development of clinical research industry in medical institutions also requires more high-quality supporting supplier cooperation in IIT and achievement transformation. Moreover, the competition among biopharmaceutical companies is intensifying, and there is an urgent need to improve research and development efficiency and reduce clinical operating costs. By organizing clinical research institutions and enterprises to participate in exhibitions, promoting sufficient communication and transactions between the supply and demand sides of clinical research resources, it will undoubtedly promote the integrated development of the clinical research industry

organizational structure

Guidance unit:

Guangzhou Municipal Health Commission

Guangzhou Cooperation Office

Host:

Office of Guangzhou Expo Organizing Committee

Guangdong Kuaicai Exhibition Co., Ltd

Co organizer:

Guangzhou Hospital Association

Guangzhou Development Zone Biomedical Hospital and Health Industry Promotion Association

Undertaking Unit:

Guangdong Yinling Health Industry Co., Ltd

Co organizer:

Guangzhou Research Hospital Alliance

Guangzhou New Pharmaceutical and Medical Device Innovation Alliance

Exhibition Background

The Clinical Research Association is a professional brand exhibition incubated on the Guangzhou Expo platform hosted by the Guangzhou Municipal People's Government. It is jointly guided and organized by the Guangzhou Municipal Health Commission and the Guangzhou Cooperation Office, and has received strong support from leaders at all levels such as the National Health Commission, Guangzhou Municipal People's Government, Guangdong Provincial Health Commission, Guangzhou Municipal Health Commission, Guangzhou Medical Insurance Bureau, Guangzhou Municipal Bureau of Industry and Information Technology, and Guangzhou Municipal Bureau of Science and Technology. Since its establishment, the Clinical Research Association has attracted more than 80000 visitors from GCP institutions, CROs, SMOs, sponsors, clinical trial service providers, media, and industry to visit and exchange ideas. It has signed more than 1000 letters of intent for project cooperation. The Clinical Research Association clearly aims to facilitate clinical research project negotiations, transactions, and cooperation, and to assist medical enterprises in clinical trials. Research project docking.

Simultaneous activities

Clinical Research High Quality Development Forum
Forum on Industrialization Development of Clinical Research in Medical Institutions
Clinical Research Training Course and Quality Control Officer Capability Enhancement Course
Exchange and sharing of experience in clinical trial operation management
Roadshow Promotion of Collaborative Innovation and Development between Medical Enterprises
Roadshows for medical institutions, CROs, and sponsors
On site signing of clinical trial projects

Why participate in CRE Clinical Research Conference

Exhibition scope

（1） Medical institutions with GCP qualifications or other medical institutions interested in developing the clinical research industry.

（2） Clinical research product and service providers: clinical trial institution filing counseling consulting agencies, contract research organizations (CROs)/academic research organizations (AROs), clinical research information system and solution providers, data management and biostatistics and pharmacovigilance companies, biological sample testing companies, research center management organizations (SMOs), clinical trial insurance, cold chain/logistics/biological sample storage suppliers, biopharmaceutical parks, literature search/medical writing/medical translation, intellectual property legal services, etc.

（3） Pharmaceutical and device research and development enterprises: biopharmaceutical research and development enterprises, pharmaceutical enterprises, device enterprises, stem/somatic cell drug research and development enterprises, etc.

（4） Related institutions and service providers for achievement transformation: Medical institution achievement transformation display, including innovative achievements of medical institutions in medical technology, diagnostic methods, treatment methods, drug research and development, medical equipment improvement, cooperation projects and achievements between medical institutions and other scientific research institutions, enterprises, government departments, achievement transformation service institutions, research and development units undertaking medical institution achievement transformation, investment and financing institutions, etc.

Audience group

1. Clinical research industry: leaders of clinical research departments in medical institutions, heads of relevant departments in clinical research management, department discipline leaders/researchers, suppliers of the clinical research industry chain, clinical research related practitioners (sponsors, CRO and SMO clinical operation directors, PM, SSU leaders, institutional cooperation leaders, post market project leaders, medical, BD, QA, CRA, CRC, etc.).

2. Government units: leaders or representatives of relevant government departments such as the National Health Commission, Drug Administration, Medical Insurance Bureau, Centers for Disease Control and Prevention, Civil Affairs, National Development and Reform Commission, and Industry and Information Technology.

3. Others: hospitals and medical institutions, healthcare institutions, social organizations, medical channel providers, investment and trade institutions, industrial parks, etc.

Prev Event Review: The Regional Training Course on High Quality Development of Clinical Research and Scientific Research Management Ability in Modern Hospitals is now underway! Next Got it! The central government issued 2.796 billion yuan